March 2018 FDA Recall Drug by Johnson Matthey Inc.
D-1077-2019 - Microbial Contamination of Non-Sterile Products
This Class II drug recall was voluntarily initiated by Johnson Matthey Inc. on March 5, 2018 for the product Drug. The FDA reported the reason for recall as microbial contamination of non-sterile products. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-1077-2019
Microbial Contamination of Non-Sterile Products: Bioburden out of specification results for Morphine Sulfate API.
03-05-2018
04-10-2019
169.976 kg
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Johnson Matthey Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide in the US
07-23-2021
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Morphine Sulfate USP Milled, Active Pharmaceutical Ingredient, Rx only, Johnson Matthey Pharmaceutical Materials, 2003 Nolte Drive, West Deptford, NJ 08066-1742
Batch or Lot Expiration Information
Lot# B1414-160809, Retest Date AUG 2021